GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Symbiotec Pharmalab Ltd

Symbiotec Pharmalab Ltd: Adopts Fair Disclosure Code for Insider Trading

REGULATORY ● No Immediate Change LOW RISK
📅 Filed on BSE: 01 Sep 2026, 03:41 PM IST  ·  BSE ID: bf44c09a-1716-4e1b-a7a6-605434a5800c
View Original BSE Filing (PDF)
💡
In Simple Terms
The company established rules for sharing important inside information fairly and promptly with everyone.
🤖 AI Summary
  • Symbiotec Pharmalab adopted its Fair Disclosure Code for Unpublished Price Sensitive Information.
  • The adoption is mandated by Regulation 8(2) of SEBI's Prohibition of Insider Trading Regulations, 2015.
  • The company has framed the code under Regulation 8(1) of the SEBI PIT Regulations.
  • This filing serves as an intimation to the BSE and NSE for their records.
🏢 How This Affects the Company
⚙️
Operational Impact
The company now has a formal, documented procedure for managing and disclosing sensitive information.
⚠️
Risk Impact
This filing proactively addresses regulatory requirements, mitigating potential compliance risks related to insider trading.
👥 What This Means For Shareholders
✅
Action Required
No action is required by shareholders. This is a corporate governance compliance update.
👤
Who Is Affected
All shareholders are indirectly affected by the enhanced corporate governance framework ensuring fair information access.
🔍
Management Signal
Management signals a commitment to regulatory compliance and transparent information practices.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Future disclosures under the new fair disclosure code.
Any potential updates or amendments to the adopted code.
Subsequent company announcements for adherence to PIT regulations.
LOW RISK This filing concerns procedural compliance with SEBI regulations and carries no inherent new risks.
💡 Investor Takeaway
Symbiotec Pharmalab has adopted a SEBI-mandated code for fair disclosure of price-sensitive information, reinforcing governance practices.
❓ Frequently Asked Questions
What has Symbiotec Pharmalab Ltd filed regarding insider trading?
Symbiotec Pharmalab Ltd has filed an intimation regarding the adoption of its Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information.
Which SEBI regulation requires Symbiotec Pharmalab Ltd to adopt this code?
Symbiotec Pharmalab Ltd is adopting the code under Regulation 8(2) of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.
What is the purpose of the Fair Disclosure Code adopted by Symbiotec Pharmalab Ltd?
The code ensures fair and timely dissemination of unpublished price sensitive information to all stakeholders, in line with SEBI regulations.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.